Certified by Founder
Lodge
Xenocor
start up
United States
- Salt Lake City, Utah
- 19/04/2023
- Series A
- $10,000,000
Xenocor is actively solving challenges in minimally invasive surgery by bringing the Saberscope single-use, fog-free, articulating laparoscopic platform to market.
Xenocor is a privately held corporation, based in Salt Lake City, UT. Learn more at: www.saberscope.com/resources
- Industry Medical Equipment Manufacturing
- Website https://xenocor.com/
- LinkedIn https://www.linkedin.com/company/xenocor/
Related People
Charles DeCoster IVFounder
United States -
Washington, Utah
Life Sciences senior leader specializing in Investor Relations, Strategy, Business Development/M&A, Upstream Marketing and Portfolio Management
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)